Emily L Esakov Rhoades

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 13, 2023
Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer.

Erin E Mulkearns-Hubert, Emily Esakov Rhoades, Salma Ben-Salem

|Jun 28, 2023
Unrestricted Ketogenic Diet Feeding Enhances Epithelial Ovarian Cancer Growth In Vivo.

Mariam M AlHilli, Emily E Rhoades, Danielle Chau

|Oct 07, 2022
Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.

Laura M Chambers, Emily L Esakov Rhoades, Rashmi Bharti

|Aug 27, 2021
Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1.

Harrison T Muturi, Saja S Khuder, Hilda E Ghadieh

|Apr 30, 2021
Islet Dysfunction in a Novel Transgenic Model of T Cell Insulitis.

Emily Esakov, Neha Nandedkar-Kulkarni, Ali G Al-Dieri

Pageof 1

Frequent Collaborators

2 joint publications

Marcia F McInerney

2 joint publications

Rashmi Bharti

2 joint publications

Ofer Reizes

2 joint publications

Justin D Lathia